Bizacumen Inc., Nov 2009, Pages: 277
and Small Companies
5. MARKET TRENDS & ISSUES
Market Consolidations on the Way to Integrate In Vivo and In
Vitro Diagnostics
Global Molecular Diagnostics on HighGrowth Curve
Pharmaceutical Firms Carving
Markets and Markets, April 2010, Pages: 139
questions answered:
- Which are the high-growth segments/cash cows and how is the market segmented in terms of market directed diagnostic ECG?
- What are market estimates and forecasts; which markets
JZMed Inc., Jan 2011, Pages: 282
in genomics and proteomics research. They are also diligently applying the technologies to developing biomarkers and new diagnostic products. Moreover, the fast growth of the Chinese economy which makes more
Bizacumen Inc., Nov 2009, Pages: 249
in DNA array technologies are major growth facilitators for the DNA probes-based diagnostic products market.
In the area of molecular in-vitro diagnostics, DNA based diagnostics represent the most
TriMark Publications, May 2011, Pages: 3057
and marketing high-growthdiagnostic testing technologies in the clinical hospital market. It defines the dollar volume of sales, both worldwide and in the U.S., of the market and analyzes the factors
Renub Research, Sep 2010, Pages: 89
analytical insight on the market dynamics. The report reviews the competitive landscape in terms of mergers and acquisitions, licensing, pipeline products and new technology offerings. The report also analyses
China Research & Intelligence, April 2009, Pages: 60
technologies.
Although in its beginning phase, the high profit return attracts many investors to enter Chinese diagnostic reagent industry. On 5th June, 2007, the first multinational capital import
Frost & Sullivan, Nov 2007, Pages: 140
, reagent sales and market demand for these tests will continue to rise over the long term.The market for haematolgy diagnostics in Europe is highly competitive, compelling continued time and investment
Decision Resources, Inc., March 2010, Pages: 32
for imaging market.
- Opportunities for industry growth: New technologies featuring improved diagnostic capabilities, enhanced software development and advancing information technology, clinical
Bizacumen Inc., Nov 2009, Pages: 158
Molecular diagnostics and the Human Genome Project have been the major growth drivers for gene amplification technology. Amplification is a mechanism by which cells are amplified or synthesized from
Business Insights, March 2009, Pages: 160
structure, financial performance, growth strategies and R&D activity. Growth forecasts for key products and regions are also provided.
Key Findings
The global in-vitro diagnostics (IVD) market is forecast
Frost & Sullivan, Feb 2008, Pages: 221
for the growth of diagnostic instruments."
Developments are expected to slow with respect to high-quality and cost-effective diagnostic instruments. "The need to master diagnostic measurement capabilities
Axis Research Mind, Nov 2011, Pages: 342
potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug
Transparency Market Research, Nov 2011, Pages: 108
and contribution to the overall Cardiovascular Monitoring and Diagnostic devices market
- Analyze opportunities in the market for stakeholders by identifying high-growth segments of the global Cardiovascular
TriMark Publications, Nov 2008, Pages: 310
OF TABLES
Table 1.1: Emerging Technology Platforms Driving High-GrowthDiagnostics Market Segments 12
Table 1.2: Market Trends in the High-GrowthDiagnostics Space 13
Table 2.1: U.S. Population Dynamics
Bizacumen Inc., Nov 2009, Pages: 195
Diagnostics: A Global Market Perspective" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses. DIABETES DIAGNOSTICS
Select Biosciences Ltd, Jan 2010, Pages: 128
analysis. No longer are large groups of cells containing high and low responders, early and late responders and fast and slow responders averaged into oblivion. ’Omics technologies are beginning to be used
Frost & Sullivan, June 2009, Pages: 54
This research service analyses the revenue potential for HIV/AIDS and Hepatitis B/C molecular diagnostics markets in major western European countries. It also gives the overview
Frost & Sullivan, Aug 2007, Pages: 85
to help vendors gain an advantage in the market. The research service also discusses coagulation diagnostics options that are available with respect to laboratory and POC testing.
Technologies
CYGNUS Business Consulting & Research, April 2009, Pages: 67
, Indian market scenario and major markets.
- The report analyses the facts regarding the accreditions & quality control aspects in diagnostics and pathology market.
- It presents the growth drivers
